Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Alopecia Market: By Disease Type: Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis; By Drug Type; By Route of Administration; By Gender; By Distributional Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments
Global Alopecia Market Outlook
The global alopecia market size was estimated at USD 2.8 billion in 2020 and is anticipated to grow over the forecast period of 2022-2027 at a CAGR of 8.6%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
There are many different kinds of alopecia, each with a distinct cause. As is prevalent in male pattern baldness, alopecia can be located at the front and top of the head. It may be patchy as in an alopecia areata disorder. The alopecia market can be divided on the basis of segments like disease type, drug type, route of administration, gender, and distribution channel.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global alopecia market can be broadly categorised on the basis of disease type into:
- Androgenic Alopecia
- Alopecia Areata
- Ciatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
The industry can be divided on the basis of drug type as:
- Minoxidil
- Finasteride
- Others
The global alopecia market can be categorised based on route of administration as:
- Oral
- Topical
- Injectable
The industry can be divided based on gender as:
- Males
- Females
The global alopecia market can be divided on the basis of the distribution channel as:
- Hospitals
- Retail Pharmacies
- Online Pharmacies
The EMR report looks into the regional markets of alopecia like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Alopecia Market Analysis
It is expected that the occurrence of Polycystic Ovary Syndrome (PCOS), cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses will drive the global alopecia market. Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are regarded as powerful triggers for alopecia. While the precise causative factors stay unknown, genetic factors are associated with several instances. Increasing disposable earnings and increasing emphasis on aesthetic appearances are anticipated to contribute to the demand for therapy of alopecia. Hormonal imbalance and ageing accelerate the growth of hair loss instances, further aiding the global alopecia market growth. The overall increase in the geriatric population and rising customer consciousness of therapy alternatives are also anticipated to have a positive impact on the global alopecia market in the following years. During the forecast period, the product development of new therapeutic alternatives is anticipated to drive the industry growth. Other factors driving the industry include the introduction of fast-acting JAK inhibitors, the development of techniques to boost hair growth using human pluripotent stem cells, and PRP therapy.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global alopecia market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Cipla Ltd.
- Capillus LLC
- Freedom Laser Therapy, Inc.
- Apira Science, Inc.
- HairMax (Lexington Intl., LLC)
- Follica, Inc.
- Incyte Corporation
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Disease Type, Drug Type, Route of Administration, Gender, Distributional Channel, Region |
| Breakup by Disease Type | Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis |
| Breakup by Drug Type | Minoxidil, Finasteride, Others |
| Breakup by Route of Administration | Oral, Topical, Injectable |
| Breakup by Gender | Males, Females |
| Breakup by Distribution Channel | Hospitals, Retail Pharmacies, Online Pharmacies |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., Incyte Corporation, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Alopecia Market Analysis
8.1 Key Industry Highlights
8.2 Global Alopecia Historical Market (2017-2021)
8.3 Global Alopecia Market Forecast (2022-2027)
8.4 Global Alopecia Market by Disease Type
8.4.1 Androgenic Alopecia
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Alopecia Areata
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Ciatricial Alopecia
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Traction Alopecia
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Alopecia Totalis
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.5 Global Alopecia Market by Drug Type
8.5.1 Minoxidil
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Finasteride
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Others
8.6 Global Alopecia Market by Route of Administration
8.6.1 Oral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Topical
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Injectable
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.7 Global Alopecia Market by Gender
8.7.1 Males
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Females
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.8 Global Alopecia Market by Distribution Channel
8.8.1 Hospitals
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2017-2021)
8.8.1.3 Forecast Trend (2022-2027)
8.8.2 Retail Pharmacies
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2017-2021)
8.8.2.3 Forecast Trend (2022-2027)
8.8.3 Online Pharmacies
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2017-2021)
8.8.3.3 Forecast Trend (2022-2027)
8.9 Global Alopecia Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Cipla Ltd.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Capillus LLC
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Freedom Laser Therapy, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Apira Science, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 HairMax (Lexington Intl., LLC)
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Follica, Inc.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Incyte Corporation
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Alopecia Market: Key Industry Highlights, 2017 and 2027
2. Global Alopecia Historical Market: Breakup by Disease Type (USD Billion), 2017-2021
3. Global Alopecia Market Forecast: Breakup by Disease Type (USD Billion), 2022-2027
4. Global Alopecia Historical Market: Breakup by Drug Type (USD Billion), 2017-2021
5. Global Alopecia Market Forecast: Breakup by Drug Type (USD Billion), 2022-2027
6. Global Alopecia Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
7. Global Alopecia Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
8. Global Alopecia Historical Market: Breakup by Gender (USD Billion), 2017-2021
9. Global Alopecia Market Forecast: Breakup by Gender (USD Billion), 2022-2027
10. Global Alopecia Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
11. Global Alopecia Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
12. Global Alopecia Historical Market: Breakup by Region (USD Billion), 2017-2021
13. Global Alopecia Market Forecast: Breakup by Region (USD Billion), 2022-2027
14. North America Alopecia Historical Market: Breakup by Country (USD Billion), 2017-2021
15. North America Alopecia Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Europe Alopecia Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Europe Alopecia Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Asia Pacific Alopecia Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Asia Pacific Alopecia Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Latin America Alopecia Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Latin America Alopecia Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Middle East and Africa Alopecia Historical Market: Breakup by Country (USD Billion), 2017-2021
23. Middle East and Africa Alopecia Market Forecast: Breakup by Country (USD Billion), 2022-2027
24. Global Alopecia Market Structure
Key Questions Answered in the Report
In 2020, the global alopecia market attained a value of nearly USD 2.8 billion.
The market is projected to grow at a CAGR of 8.6% between 2021 and 2026.
The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses.
Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The major disease types of alopecia in the market are androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis.
The significant drug types in the industry are minoxidil and finasteride, among others.
The leading routes of administration in the market are oral, topical, and injectable.
The major gender segments in the industry are males and females.
The significant distribution channels in the market are hospitals, retail pharmacies, and online pharmacies.
The major players in the industry are Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others.
Analyst Review
The global alopecia market attained a value of USD 2.8 billion in 2020, driven by the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses. Aided by the changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 8.6%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on disease type, the alopecia industry can be segmented into androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. On the basis of drug type, the market is divided into minoxidil, finasteride, and others. The industry can be segregated based on route of administration into oral, topical, and injectable. The market is bifurcated on the basis of gender into males and females. Based on distribution channel, the industry can be classified into hospitals, retail pharmacies, and online pharmacies. The major regional markets for alopecia are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
The Asia Pacific vaccine market attained a value of nearly USD 3.92 billion in 2021, driven by the robust growth of the healthcare sector. Aided by the increasing research and development (R&D) activi...
The global microencapsulation market attained a value of about USD 9.52 billion in 2021, driven by the advancements in the pharmaceutical and nutraceutical industries. Aided by growing inclination tow...
The global anti-infectives market attained a value of about USD 118.36 billion in 2021, driven by the rising prevalence of infectious diseases. Aided by large scale investments into the pharmaceutical...
The global liposomal doxorubicin market attained a value of more than USD 1,100 million in 2021, driven by the increase in breast and ovarian cancer cases, as well as increased awareness of the advant...
NEWSLETTER